Literature DB >> 33256074

SAHA Overcomes 5-FU Resistance in IFIT2-Depleted Oral Squamous Cell Carcinoma Cells.

Prabha Regmi1,2, Kuo-Chu Lai3, Chung-Ji Liu4, Te-Chang Lee2.   

Abstract

Interferon-induced protein with tetratricopeptide repeats 2 (IFIT2) is a member of the interferon-stimulated gene family that contains tetratricopeptide repeats (TPRs), which mediate protein-protein interactions in various biological systems. We previously showed the depletion of IFIT2 enhanced cell migration and metastatic activity in oral squamous cell carcinoma (OSCC) cells via the activation of atypical PKC signaling. In this study, we found that IFIT2-knockdown cells displayed higher resistance to 5-fluorouracil (5-FU) than control cells. The comet assay and annexin V analysis showed decreased DNA damage and cell death in IFIT2-knockdown cells compared to control cells treated with 5-FU. Cell cycle progression was also perturbed by 5-FU treatment, with the accumulation of IFIT2-depleted cells in S phase in a time-dependent manner. We further observed the overexpression of thymidylate synthase (TS) and thymidine kinase (TK) in IFIT2-knockdown cells. Inhibition of TS alone or double inhibition of TS and TK1 using the siRNA technique increased susceptibility to 5-FU in IFIT2-knockdown cells. We further identified that suberanilohydroxamic acid (SAHA) treatment decreased the expression of TS in IFIT2-knockdown cells and demonstrated that pretreatment with SAHA sensitized IFIT2-knockdown cells to 5-FU in vitro and in vivo. In conclusion, IFIT2 knockdown enhances TS expression, which mediates 5-FU resistance, and SAHA pretreatment suppresses TS expression and hence sensitizes cells to 5-FU. SAHA will be an effective strategy for the treatment of OSCC patients with 5-FU resistance.

Entities:  

Keywords:  5-FU; IFIT2; SAHA; drug resistance; oral squamous cell carcinoma

Year:  2020        PMID: 33256074      PMCID: PMC7761248          DOI: 10.3390/cancers12123527

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  72 in total

1.  Combination of bifunctional alkylating agent and arsenic trioxide synergistically suppresses the growth of drug-resistant tumor cells.

Authors:  Pei-Chih Lee; Rajesh Kakadiya; Tsann-Long Su; Te-Chang Lee
Journal:  Neoplasia       Date:  2010-05       Impact factor: 5.715

Review 2.  A comparison of toxicity profiles between the lower and standard dose capecitabine in breast cancer: a systematic review and meta-analysis.

Authors:  Tomohiro F Nishijima; Maya Suzuki; Hyman B Muss
Journal:  Breast Cancer Res Treat       Date:  2016-03-17       Impact factor: 4.872

3.  Curcumin induces apoptosis in human leukemic cell lines through an IFIT2-dependent pathway.

Authors:  Yonglu Zhang; Yunyuan Kong; Shuyuan Liu; Lingbing Zeng; Lagen Wan; Zhanglin Zhang
Journal:  Cancer Biol Ther       Date:  2017-01-10       Impact factor: 4.742

Review 4.  Cetuximab in the treatment of head and neck cancer.

Authors:  Jacques Bernier
Journal:  Expert Rev Anticancer Ther       Date:  2006-11       Impact factor: 4.512

Review 5.  The ISG56/IFIT1 gene family.

Authors:  Volker Fensterl; Ganes C Sen
Journal:  J Interferon Cytokine Res       Date:  2010-10-15       Impact factor: 2.607

6.  Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma.

Authors:  D M Shin; F R Khuri; B S Glisson; L Ginsberg; V M Papadimitrakopoulou; G Clayman; J J Lee; K K Ang; S M Lippman; W K Hong
Journal:  Cancer       Date:  2001-04-01       Impact factor: 6.860

Review 7.  Thymidylate synthase and drug resistance.

Authors:  G J Peters; C L van der Wilt; B van Triest; G Codacci-Pisanelli; P G Johnston; C J van Groeningen; H M Pinedo
Journal:  Eur J Cancer       Date:  1995 Jul-Aug       Impact factor: 9.162

8.  Depleting IFIT2 mediates atypical PKC signaling to enhance the migration and metastatic activity of oral squamous cell carcinoma cells.

Authors:  K C Lai; C J Liu; K W Chang; T C Lee
Journal:  Oncogene       Date:  2012-09-17       Impact factor: 9.867

9.  Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase.

Authors:  E Di Gennaro; G Piro; M I Chianese; R Franco; A Di Cintio; T Moccia; A Luciano; I de Ruggiero; F Bruzzese; A Avallone; C Arra; A Budillon
Journal:  Br J Cancer       Date:  2010-11-02       Impact factor: 7.640

Review 10.  IFITs: Emerging Roles as Key Anti-Viral Proteins.

Authors:  Gregory I Vladimer; Maria W Górna; Giulio Superti-Furga
Journal:  Front Immunol       Date:  2014-03-10       Impact factor: 7.561

View more
  1 in total

1.  IFIT2-depleted metastatic oral squamous cell carcinoma cells induce muscle atrophy and cancer cachexia in mice.

Authors:  Kuo-Chu Lai; Zi-Xuan Hong; Jyh-Gang Hsieh; Hui-Ju Lee; Muh-Hwa Yang; Chia-Husu Hsieh; Cheng-Han Yang; Yan-Ru Chen
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-02-15       Impact factor: 12.910

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.